The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
RWE Data presentation
Claims & Support/References for Claims
1
Posts
1
Posters
65
Views
2
Watching
-
Hello,
Can you please clarify for RWE study presentations, if the footnotes (e.g. for study design, etc.) need to appear within the grey box and hence, before the fair balance - or after the fair balance (which would place it outside the grey box?) We have received two slightly different directions from PAAB on the placement of RWE study footnotes. Thanks.